Profile
Cynthia J.
Ladd held several positions in different firms throughout her career.
She started as an Associate at Wilson Sonsini Goodrich & Rosati Foundation in 1984 and later worked as an Associate at DLA Piper LLP (United States) from 1986 to 1989.
From 1989 to 2000, she worked at Genentech, Inc. as the Chief Corporate Counsel & VP-Corporate Law.
She then worked as a Senior Vice President at Pharmacyclics LLC from 2000 to 2003 and later became the President & Chief Executive Officer at AGY Therapeutics, Inc. from 2003 to 2005.
She also worked as a Principal at Gray Cary Ware & Freidenrich LLP.
From 2015 to 2018, she was the Senior Vice President & General Counsel at CytomX Therapeutics, Inc. Ms. Ladd's most recent position was as the General Counsel at MyoKardia, Inc. from 2018 to 2021.
Ms. Ladd received her undergraduate degree from The Pennsylvania State University in 1977, her graduate degree from Cornell University in 1980, and her graduate degree from Stanford Law School in 1984.
Former positions of Cynthia J. Ladd
| Companies | Position | End |
|---|---|---|
| MYOKARDIA, INC. | General Counsel | 2020-12-31 |
| CYTOMX THERAPEUTICS, INC. | General Counsel | 2018-04-13 |
AGY Therapeutics, Inc.
 AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Chief Executive Officer | 2005-05-31 |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | 2002-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 1999-12-31 |
Training of Cynthia J. Ladd
| Cornell University | Graduate Degree |
| Stanford Law School | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
AGY Therapeutics, Inc.
AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Gray Cary Ware & Freidenrich LLP | Commercial Services |
| Wilson Sonsini Goodrich & Rosati Foundation | |
DLA Piper LLP (United States)
 DLA Piper LLP (United States) Miscellaneous Commercial ServicesCommercial Services DLA Piper LLP provides legal services to clients. It offers services in the areas of corporate and securities, venture capital and emerging companies, litigation. The company was founded in 2005 and it is headquartered in Baltimore, MD. | Commercial Services |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Cynthia J. Ladd
